Financials

  • Market Capitalization 38.46 B
  • Employee 2 500
  • Founded 2002
  • CEO Yvonne Greenstreet
  • Website www.alnylam.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000BFGNJ5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
170.67
Price to sales ratio
14.42

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
294
ARGX
argenx SE - American Depositary Shares
871.80 USD-0.66%-6.02%-3.13%+56.02%53.95 B USD
382
RVMD
Revolution Medicines, Inc. - Common Stock
181.70 USD-2.77%-4.07%+18.73%+227.98%38.63 B USD
496
MRNA
Moderna, Inc. - Common Stock
66.76 USD-2.21%-18.01%+33.57%+100.42%26.49 B USD
516
ROIV
Roivant Sciences Ltd. - Common Shares
34.48 USD-4.14%-2.43%+14.93%+88.31%24.80 B USD

Frequently asked questions about Alnylam Pharmaceuticals, Inc. - Common Stock

What is the Alnylam Pharmaceuticals, Inc. - Common Stock stock price today?

The current price of Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) is 288.06. Over the past 24 hours, the stock has changed by -3.58%. Follow the ALNY chart for real-time price dynamics.

What is the stock ticker of Alnylam Pharmaceuticals, Inc. - Common Stock?

Alnylam Pharmaceuticals, Inc. - Common Stock trades under the ticker ALNY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Alnylam Pharmaceuticals, Inc. - Common Stock stock going up?

ALNY has changed by -8.97% over the last week, -0.31% over the last month, and -8.53% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Alnylam Pharmaceuticals, Inc. - Common Stock net income for the last quarter?

Alnylam Pharmaceuticals, Inc. - Common Stock reported net income of 205.99 M for the last quarter. The previous quarter showed 111.54 M, which means net income changed by +84.67%.

How many employees does Alnylam Pharmaceuticals, Inc. - Common Stock have?

As of the latest available data, Alnylam Pharmaceuticals, Inc. - Common Stock has 2 500 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Alnylam Pharmaceuticals, Inc. - Common Stock stock?

You can buy Alnylam Pharmaceuticals, Inc. - Common Stock (ALNY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Alnylam Pharmaceuticals, Inc. - Common Stock stock?

Investing in Alnylam Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALNY chart and related analysis on metatrader.com as part of your research.

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

News